The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. A variety of strategies can be employed to antibody titer, comprising process parameter optimization, cell line development, and implementation of perfusion systems. Fine-tuning media compos